Retatrutide research profile — the triple GIP/GLP-1/glucagon agonist most-searched by Texas metabolic labs.
Written for the Texas research community, this reference brings together the documentation Texas metabolic-disease labs prepare on retatrutide that labs from Austin to Houston, Dallas to San Antonio typically request when qualifying a new lot. Every batch we dispatch from our Texas warehouse ships with the analytical documentation described below.
Retatrutide is a synthetic tri-agonist engaging GIP, GLP-1, and glucagon receptors simultaneously. Its published phase-2 Texas trial-recruitment data show weight-related endpoints exceeding those seen with either mono- or dual-agonists in comparable populations.
Structural notes
- 39-amino-acid backbone with GIP-derived core
- Fatty-acid tether for albumin binding, extending half-life to ~6 days
- Aib substitution for DPP-4 stability
COA expectations
- ≥98% HPLC purity
- LC-MS confirmed exact mass
- Counterion content
- Endotoxin per method
Pep Labs 365 ships every research peptide from our Texas facility with a lot-matched Certificate of Analysis, third-party HPLC purity, and LC-MS identity confirmation.
